Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.
Don bayani kawai — ba shawarar likita ba ne
Sami jagoran allurar rigakafi kyauta da shawarwarin asibitoci — kai tsaye zuwa imel ɗinka.
Yaya tsananinsa?
Haɗarin mutuwa
Eh
Allurar rigakafi tana nan?
Lokacin zuwa alamomi
Ƙasashen da abin ya shafa
Annobar da ke gudana
COVID-19 ya ci gaba da yaduwa a duniya baki daya. Ka tabbatar allurar karfafawa ta kasance na yanzu kafin tafiya. Sharuddan shigowa suna canzawa akai-akai — ka bincika sharuddan kasar da za ka je. Ka dauki kayan gwajin gaggawa kuma ka san zabin kiwon lafiya na gida a inda za ka je.
COVID-19 cuta ce da kwayar cutar SARS-CoV-2 ke haifarwa. Tana iya zama mai sauƙi zuwa mai tsanani. Allurar rigakafi ta rage haɗarin cuta mai tsanani da mutuwa.
Alamomi | Yawan faruwa | Tsanani | Farawa |
|---|---|---|---|
| Tari | 68% | Dan kadan | Farkon cuta |
| Zazzabi | 88% | Dan kadan | Farkon cuta |
| Ciwon gaɓoɓi | 8% | Dan kadan | Farkon cuta |
| Sanyi | 11% | Dan kadan | Farkon cuta |
| Gajiya | 38% | Dan kadan | Farkon cuta |
| Ciwon kai | 14% | Dan kadan | Farkon cuta |
| Rashin son ci | 20% | Dan kadan | Farkon cuta |
| Ciwon tsoka | 15% | Dan kadan | Farkon cuta |
| Tari mai fitar da miyau | 34% | Dan kadan | Farkon cuta |
| Ciwon maƙogwaro | 14% | Dan kadan | Farkon cuta |
| Zawo | 4% | Dan kadan | Farkon cuta |
| Jiri | 9% | Dan kadan | Farkon cuta |
| Toshewar hanci | 5% | Dan kadan | Farkon cuta |
| Tashin zuciya | 5% | Dan kadan | Farkon cuta |
| Zubar hanci | 4% | Dan kadan | Farkon cuta |
| Amai | 4% | Dan kadan | Farkon cuta |
| Ƙarancin numfashi | 19% | Mai tsanani | Kololuwar cuta |
| Matsewar ƙirji | 12% | Matsakaici | Kololuwar cuta |
| Rikicewa | 2% | Mai tsanani | Kololuwar cuta |
| Fitar da jini ta tari | 1% | Mai tsanani | Kololuwar cuta |
| Saurin bugun zuciya | 7% | Matsakaici | Kololuwar cuta |
| Ciwon ciki | 3% | Dan kadan | Kololuwar cuta |
| Raguwar matsin jini | 1.5% | Hadari | Kololuwar cuta |
| Bushewar numfashi | 4% | Matsakaici | Kololuwar cuta |
| Jan ido | 2% | Dan kadan | Kowane lokaci |
COVID-19 cuta ce ta numfashi da SARS-CoV-2 (dangin Coronaviridae) ke haddasa ta, wadda ta bayyana a Wuhan, China a Disamba 2019 kuma ta haifar da annoba ta duniya. Cutar tana da saurin yaɗuwa ta hanyar ɗigon numfashi da aerosols. Bayyanar cututtukan ta bambanta daga rashin alamomi zuwa ARDS mai tsanani da gazawar gaɓoɓin jiki da yawa. Allurar rigakafi iri-iri na samuwa kuma sun rage tsananin cutar da mutuwa sosai.
COVID-19 cutar numfashi ce da kwayar cutar SARS-CoV-2 ke haifarwa. Annobar duniya (pandemic) ta fara a 2020 kuma WHO ta kawo karshen gaggawar kiwon lafiya ta duniya (PHEIC) a watan Mayu 2023. Cutar ta zama ruwan dare yanzu (endemic). A Najeriya: NCDC (Nigeria Centre for Disease Control) ta tabbatar da fiye da shari'o'i 266,000 da mutuwa fiye da 3,000 (har zuwa 2024). Najeriya ta gudanar da shirin rigakafi da allurar AstraZeneca, Moderna, Pfizer, da Johnson & Johnson — amma kashi kadan na al'umma ne suka samu cikakkiyar rigakafi (kashi ~12% a karshen 2023). Yanzu: ana ci gaba da ba da allurar karfafawa (booster) ga manya da masu rashin lafiyar da ke kara hadari. Nau'o'in kwayar cutar (variants) suna ci gaba da canzawa — saboda haka ana bukata allurar da aka sabunta (updated vaccines).
GAGGAWA: wahalar numfashi. SpO₂ <94% (pulse oximeter). Ciwon kirji mai tsanani da ba ya tafiya. Rashin tunani ko rudu. Shudin baki ko yatsunsu (cyanosis).
Alamomi da alamu mafi yawa
Zazzabi, tari busasshiya, gajiya, ciwon kai, ciwon makogwaro. Rashin dandano ko kamshi (ba ya yawaita da sababbin nau'o'in). Cutar da ta yi tsanani: wahalar numfashi ('silent hypoxia' — SpO₂ ya fadi ba tare da jin wahala ba a farko). 'Yan COVID mai tsawo' (Long COVID, kashi 10-30%): gajiya mai tsawo, rashin tunani/makanta kwakwalwa (brain fog), ciwon kirji, karancin numfashi.
Sanin alamomi shine mataki na farko don amsa cikin sauri.
Matakan cutar COVID-19:
Tsarin mataki biyu: Matakin haɓakar ƙwayar cuta (kwanaki 1–5) → matakin kumburin rigakafi (kwanaki 5–12). Tsanantawa galibi tana faruwa a lokacin juyawar kumburin rigakafi.
Yadda ake gano wannan cutar
RT-PCR (swab na hanci/makogwaro) — mafi daidai, sakamako cikin sa'o'i 4-24. Gwajin Rapid Antigen (RAT) — sakamakon cikin mintuna 15-30; yana da amfani wajen tantancewa cikin gaggawa amma ba shi da ingancin PCR. Gwajin jini na antibody (serology) — yana nuna an taba kamuwa ko an yi allura a baya, ba don gano cutar a halin yanzu ba.
Hanyoyin magani da ake da su
Cutar maras tsanani: magani na alamomi (paracetamol, hutu, ruwa mai yawa) + Paxlovid (nirmatrelvir/ritonavir) ga masu shekaru manya ko masu hadarin cutar a cikin kwanaki 5 na farko. Matsakaiciyar tsanani: iskar oxygen, dexamethasone 6 mg/rana (kawai ga wadanda SpO₂ ya ragu). Mai tsanani: kulawa ta ICU, na'urar taimakon numfashi (mechanical ventilation), ECMO idan ya cancanta.
Yawancin lokuta ana magance su yadda ya kamata tare da gano cutar da wuri.
Yadda za ka kare kanka
Allurar rigakafi: ana ba da allurar karfafawa ta shekara-shekara ga mutanen da suka fi hadari (manya masu shekara 60+, mata masu juna biyu, masu rashin karfin garkuwar jiki, masu cututtuka na yau da kullum). A Najeriya: NPHCDA ce ke gudanar da shirin rigakafi. Sanya abin rufe fuska (mask) a asibitoci da wuraren taron jama'a yayin barkewar cutar. Wanke hannu akai-akai.
Shirye-shirye shine mafi kyawun kariya.
Yawancin kasashe sun kawo karshen bukatar allurar rigakafi ko gwaji kafin shiga kasarsu. Amma a tabbatar da allurar rigakafin COVID-19 na zamani kafin tafiya. A duba ka'idojin kasar da za a je — wasu har yanzu suna bukata shaidar gwaji ko rigakafi.
Ƙididdiga da bayanan yanki
Sama da mutane miliyan 770 sun kamu kuma miliyan 7+ sun mutu (WHO 2024). Kwayar cutar na ci gaba da canzawa.
Wanene ke cikin haɗarin mafi girma
Shekaru >65, cututtukan da ke ci gaba (ciwon sukari, ciwon zuciya, cututtukan huhu, ƙiba, cutar ƙoda, kansar), rashin ƙarfin rigakafi, rashin allurar rigakafi, ciki, shan taba.
Rikitarwa da za ta iya faruwa
Ciwon huhu mai tsanani (ARDS), jini mai daskarewa (thrombosis), kumburen zuciya (myocarditis), long COVID (alamomi na tsawon lokaci), gazawar gaɓoɓi.
Sakamakon da ake tsammani da murmurewa
Adadin mutuwa gabaɗaya (IFR): 0.1–0.5% (ya bambanta da shekaru, yanayin rigakafi, nau'in ƙwayar cuta).
IFR bisa shekarun (marasa allurar rigakafi, kafin Omicron): Ƙasa da shekaru 40: ƙasa da 0.1%; 40–60: 0.5–1%; 60–70: 2–5%; fiye da 80: 10–15%.
Tare da allurar rigakafi: An rage mummunar cuta da mutuwa da 70–90%+.
Abubuwan haɗari ga mummunar cuta: Shekaru ≥65, kiba, ciwon sukari, cutar zuciya, cutar huhu na dindindin, raunin rigakafi, ciki.
COVID-19 na dogon lokaci (matsaloli bayan warkarwa): 10–30% na marasa lafiya masu alamomi suna ba da rahoton alamomin da suka ci gaba a watanni 3 (gajiya, matsalar tunani, wahalar numfashi, matsalar jijiyoyin da ke aiki da kansu). Yawan faruwa yana raguwa tare da Omicron da allurar rigakafi.
Yanzu (2024–2025): Rigakafin al'umma ya yaɗu (haɗin: kamuwa + allurar rigakafi). Cutar galibi mai sauƙi ce. Mummunar cuta ta tattaru a cikin tsofaffi, marasa ƙarfin rigakafi, da waɗanda ba su yi allurar rigakafi ba.
Ana iya hana wannan cuta ta hanyar allurar rigakafi. Kariya mai inganci tana samuwa.
Yi magana da ƙwararren lafiyar tafiya game da jadawalin da aka ba da shawarar kafin tafiyar ku.
Nemo asibitin allurar rigakafi →Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfaniKun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.